Please use this identifier to cite or link to this item:
http://tcc.fps.edu.br:80/jspui/handle/fpsrepo/310
Title: | Uso da dupla antiagregação plaquetária em pacientes idosos após síndrome coronariana aguda |
Authors: | MOTA, Gabriela de Lira Pessoa SAITO, Camila Hanae Filgueira ALMEIDA, Mariana Cavalcanti Santos de PINHEIRO, Ana Gabriela Souza Lima Kriger LEÃO, Gabriela Arruda Falcão de Souza MONTEIRO, Verônica Soares |
Keywords: | Síndrome coronariana aguda Dupla antiagregação plaquetária Sangramento Idoso |
Issue Date: | 2015 |
Abstract: | OBJECTIVE: To analyze the safety profile and effectiveness of the dual antiplatelet therapy in elderly admitted with acute coronary syndrome (ACS) in a cardiology ICU /CCU of the Real Hospital Português (RHP). METHODS: Non-concurrent cohort survey with samples of 165patients older than 65 years old, who were admitted to the cardiology ICU/CCU's RHP from February 2013 to September 2014 with clinical ACS. RESULTS: Of all the subjects studied, 87 were male and 78 female. Among patients diagnosed with ACS, 30.9% attended criteria for unstable angina, 49.7% for AMI without ST segment elevation and 19.4% for AMI with ST elevation. According to CRUSADE score, 44.44% of patients had high or very high chance of bleeding,23.33% had intermediate chance of bleeding and 34.44% had low or very low chance of having bleeding and 78.79% of patients did not have any evidence of bleeding. Of the 34 (20.60%) patients with bleeding, 52,94% were rated minimum, 32,35% were rated lower and 14,70% were rated higher. CONCLUSION: The use of dual antiplatelet therapy in elderly patients after an episode of ACS proved to be safe and effective, the majority of bleeding complications were minimum, without clinical repercussions. |
URI: | http://tcc.fps.local:80/handle/fpsrepo/310 |
Appears in Collections: | Medicina |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Uso da dupla antiagregação plaquetária.pdf | 457.11 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.